diabetestalk.net

Are Omega 3 Fats Good For Diabetes? - Diabetes Self-Management

Are Omega 3 Fats Good for Diabetes? - Diabetes Self-Management

Are Omega 3 Fats Good for Diabetes? - Diabetes Self-Management


You may have heard that omega-3 fatty acids are good for you. Is this true for people with diabetes? If so, whats the best way to get them?
A new study from England found that women who consume more omega 3s have a healthier mix of gut bacteria. These bacteria have been found to reduce the risk of obesity and Type 2 diabetes.
A study from Harvard University found that omega 3s raise levels of a hormone called adiponectin, which increases insulin sensitivity. Researchers felt this might help prevent or control Type 2 diabetes.
Omega 3s are a group of PUFAs (polyunsaturated fatty acids). There are three kinds of omega 3s. Those known as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mostly found in fish.
A third type, alpha-linolenic acid (ALA), is found in plants. The body can use ALA to produce small amounts of the other types.
All three types help reduce inflammation, prevent heart disease and stroke, and decrease insulin resistance. They seem to prevent depression and help with brain function. EPA seems to be especially important to help brains grown in childhood and to keep them strong in old age.
The other major category of PUFA is omega-6 fatty acids. We need them, too, and in close to equal amounts with omega 3s. Both types help the body make hormones that tend to balance each other out. For example, omega-6-derived hormones may start inflammation the body uses to fight infection. Omega-3-derived hormones stop inflammation when the fight is over.
The problem is the modern food environment. According to an article in Nutrition Journal, A health Continue reading

Rate this article
Total 1 ratings
Researchers emphasize community in diabetes care

Researchers emphasize community in diabetes care

Two UNM researchers are taking a community-based approach to studying diabetes self-management for low income Hispanic patients, and they have a $2.3 million grant to fund their research.
Janet Page-Reeves, lead researcher on the study, said the pair previously worked on a smaller project where they concluded that there are many people in Albuquerque’s Latino community with diabetes, and there is a high rate of people who go undiagnosed.
Page-Reeves said the survey found that, out of 100 participants, 59 tested positive for diabetes or prediabetes but only 26 knew about their condition.
The study’s community lead, Lidia Regino, took that information and turned it into a program, which is in its fifth year. One Hope Centro de Vida Health Center offers a five-part class where patients learn about diabetes management from pharmacy or medical students and then meet with medical providers to discuss their individual management plan, she said.
“Over time, Lidia had identified that she felt their work at the clinic was having really...amazing results. They were seeing people change their behavior, they felt like it was really working,” Page-Reeves said.
So the pair decided to study the program’s success with a scientific approach, she said.
Their hypothesis is that a culturally and contextually situated health promotion program will be more successful for individual patients, Page-Reeves said.
“If you have diabetes and I tell you, ‘You should join a gym,’ but you are low income, that’s not going to happen,” she said. “If I tell you to walk in your neighborhoo Continue reading

To Donald Trump, From an American With Diabetes

To Donald Trump, From an American With Diabetes

Dear President Trump,
Today you were sworn into become President of the United States.
As you were being sworn in, thousands of insulin dependent diabetics had to make a choice. Should they take a full dose of insulin and ensure their blood sugars don’t go high, or should they save some in an effort to try and make it through the month? I am one of the lucky ones, I have the resources to have private insurance. However, even with private insurance my Novolog insulin runs me over $400 out of pocket. Now imagine if I didn’t have insurance, that number would be in the thousands.
Sir, there are millions of Americans who depend on the Affordable Care Act to survive. For these Americans, the ACA isn’t merely some bill or something to argue over in the Senate, it’s a matter of life and death.
Please Donald, before you repeal the ACA, be sure to have a replacement. Why don’t you incorporate the millions of Americans who live with a chronic illness into the discussion of a replacement? The ACA isn’t perfect, but it has saved lives.
Drug prices are still too high, and far too many Americans go without vital medication because they cannot afford it, but the ACA has granted millions access to affordable health insurance, something that seemed like a dream 10 years ago.
Donald, I would invite you to listen to those with chronic illnesses and other health problems. Listen to the American people.
After all, didn’t the American people put you in office in the first place?
Lead photo by Thinkstock Images Continue reading

Popular Diabetes Medication Linked to Kidney Failure  Americas Lawyer

Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer


Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer
According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Papantonio: According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Invokana was developed by Janssen, an offshoot of Johnson & Johnson. Unlike other diabete Continue reading

Remote type 2 education platform selected for NHS Innovation

Remote type 2 education platform selected for NHS Innovation

A low-cost, online self-management platform for people with diabetes and a fully remote programme of type 2 diabetes structured education are among the latest technologies selected to join the NHS Innovation Accelerator (NIA).
A total of 11 innovations have been selected as part of an event to launch the third year of this NHS England initiative, delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs).
The NIA has supported the uptake and spread of 25 high-impact, evidence-based innovations across 799 NHS organisations since it launched in July 2015.
Each of the new innovations joining the NIA this year offer solutions to key challenges in primary care, urgent and emergency care and mental health. Recruitment onto the NIA follows an international call and robust selection process, including review by a collegiate of over 100 assessors and the National Institute for Health and Care Excellence (NICE).
Simon Stevens, NHS England chief executive said: “Modern medicine is on the cusp of a huge shift in how care is delivered, and practical innovations like these show how NHS patients will now directly benefit. More tests and patient monitoring will be done at home or on the move, without the need to pitch up to a doctor’s appointment or hospital outpatients.”
My Diabetes My Way is an interactive website for people with condition, providing comprehensive information about medication, self-management and lifestyle. online self-management platform for people with diabetes. Recent figures suggested that 88 per cent of users, felt it had helped them Continue reading

No more pages to load

Popular Articles

Related Articles